Please provide your email address to receive an email when new articles are posted on . Adrenaline and tranexamic acid each halted bleeding in 83.1% of patients. Moderate bleeding was stopped more ...

WASHINGTON, DC—Administering tranexamic acid during noncardiac surgery provides a clear reduction in bleeding, with a low likelihood of harm in terms of vascular complications, the POISE-3 trial shows ...

Tranexamic acid (TXA) failed to reduce the need for red blood cell (RBC) transfusion following surgery for liver cancer, including colorectal liver metastases, the placebo-controlled HeLiX trial ...

A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for ...

Local injection of tranexamic acid (TXA) effectively reduced the risk for clinically significant bleeding following Mohs micrographic surgery (MMS), results from a single-center cohort study showed.

Tranexamic acid (TXA) use is set to widen in England and Wales under new draft guidance from the National Institute for Health and Care Excellence (NICE). NICE recommends offering TXA before any ...

Prophylactic use of tranexamic acid at the time of cesarean delivery has been shown to decrease the calculated blood loss, but the effect on the need for blood transfusions is unclear. We randomly ...